The New Federal Reserve Chair Can Cause This Small-Cap Stock ETF to Surge

The Vanguard Small-Cap Index Fund ETF (NYSEARCA:VB | VB Price Prediction) does not hold penny stocks. VB tracks the CRSP US Small Cap Index, where the median holding is a company worth several billion dollars. With Kevin Warsh reportedly the incoming Federal Reserve Chair, the rate-cut path that small caps have been pricing in for months gets a more credible sponsor, and VB is the cheapest, broadest way to own that trade without picking individual names.

Warsh is pro rate cuts even if he is more hawkish than some of the other Trump shortlist candidates. So the easing will be gradual. Inflation is running at 3.8%, which means cuts arrive slowly, not in one dramatic move. But small caps carry more floating-rate debt than the megacaps, so even a measured easing cycle disproportionately helps the companies VB owns. That is the mechanical link between the chair pick and the fund.

What VB is

VB holds 1,300 US small-cap stocks weighted by market value, rebalanced through a buffer methodology that keeps turnover low. You collect the earnings growth and modest dividends of small American companies, and you pay one of the lowest expense ratios in the category to do it. There is no options overlay, no leverage, no factor tilt. It is the small-cap slice of the US market, delivered cheaply.

Why the structure matters: the CRSP index uses packeting bands so a stock graduating to mid-cap is migrated in stages rather than dumped on a single rebalance date. That reduces the kind of forced selling that has historically dragged on Russell-tracking funds, and it is one reason VB has quietly outperformed the better-known small-cap benchmark across longer windows. Vanguard’s mutual ownership structure also keeps the expense ratio near rock bottom, so more of the gross return reaches shareholders.

The fund has been doing its job. VB is up 10% year to date and 22% over the past year, with shares around $287. Over the past decade it has returned 156%. That is the “closing the gap” story the small-cap bulls have been telling.

Does it deliver against the obvious alternative

The honest comparison is against the iShares Russell 2000 ETF (NYSEARCA:IWM), the default small-cap vehicle most investors actually own. The two funds tell different stories depending on the window.

IWM has the better short-term tape, up 35% over one year against VB’s number, because the Russell 2000 reaches further down the cap spectrum and benefits more from a rate-cut narrative. But stretch the window. Over five years VB returned 41% versus IWM’s 29%, and over ten years the spread is wider still. CRSP’s methodology lets winners ride longer before booting them up to mid-cap, and IWM’s annual rebalance has a documented habit of selling strength. If you want torque on the Warsh thesis, IWM wins. If you want compounding, VB has the record.

The tradeoffs you actually take

1. The rate-cut path is slow. With inflation still at 3.8%, Warsh cannot move quickly even if he wants to. Small caps may give back gains every time a hot CPI print resets the timeline.
2. Earnings quality is weaker than large caps. A meaningful share of Russell 2000 and CRSP small-cap constituents do not earn money. A recession lands harder here than on the S&P 500. Liquidity is also thinner, which means drawdowns in stressed markets tend to be deeper and recoveries choppier.
3. Most investors are already accidentally underweight. Most investors are dangerously underweight small caps because cap-weighted total-market funds barely include them. Adding VB is usually just a rebalance, not a swing for the fences.

Who VB fits

VB makes sense as a 5% to 15% sleeve for an investor who owns mostly S&P 500 or total-market funds and wants a cheap, diversified way to lean into the small-cap recovery and the Warsh easing cycle. The setup is straightforward: a new chair signaling patience but openness to cuts, small-cap balance sheets that benefit disproportionately when short rates drift lower, and a starting valuation that still trades at a discount to large caps on forward earnings. None of that guarantees the trade works on any given quarter, but it does mean the risk-reward is more symmetric than it has been in years.

If you want maximum sensitivity to rate cuts and can stomach more volatility, IWM is the sharper tool. If you want a penny stock ETF, this is not that, and frankly nothing reputable is. The regulated fund universe simply does not package sub-dollar names into a diversified wrapper, and the few products that flirt with that space carry costs and liquidity risks that overwhelm any thesis. VB is the boring, durable way to own the trade.